Utility of various positron emission tomography tracers in differentiating primary central nervous system lymphoma from glioblastoma multiforme
Different PET imaging tracers help distinguish brain lymphoma from glioblastoma, refining diagnostic options for rare CNS cancers.
This retrospective single-institution study compared multiple PET tracers including FDG, 11C-methionine, 18F-FLT, and 18F-FMISO for differentiating primary CNS lymphoma from glioblastoma multiforme. The study contributes to nuclear medicine diagnostic workup for CNS malignancies but is limited by retrospective single-center design.
What the study was
- Study design
- Retrospective comparative study
- Population
- Patients with PCNSL or GBM (single institution, Japan)
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- EJNMMI Reports
Why it surfaced
PET tracer comparison for PCNSL vs GBM; clinically relevant niche topic but abstract not retrievable; title-only classification cap (≤3). Single-institution retrospective design.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.